Innocan Pharma Announces Public Filing of Registration Statement for Proposed U.S. Public Offering

HERZLIYA, Israel and CALGARY, Alberta, July 23, 2025 /CNW/ -- Innocan Pharma Corporation ("Innocan" or the "Company") (CNSX:INNO.CN) (FSE:IP4) (OTC-BB:INNPF) is pleased to announce that it has publicly filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (the "SEC") relating to a proposed public offering of units (each, a "Unit" and collectively, the "Units") in the United States.